Stewards, Inc. filed a Form 8-K on November 19, 2026, detailing the issuance of 7,000,000 shares of newly designated Series D Convertible Preferred Stock. This issuance occurred on the Amendment Effective Date of November 19, 2026, in exchange for 7,000,000 shares of common stock previously held in escrow.

The escrowed shares were associated with the acquisition of Envy Pompano Beach and related entities. Under the terms of the exchange, the escrowed shares were cancelled and returned to the status of authorized but unissued common stock. In return, the Sellers—Envy Development PB, LLC and The Myelin Group, LLC—received the Series D Preferred Stock on a one-for-one basis.

The Company issued the Series D Preferred Stock pursuant to an exemption from registration under Section 3(a)(9) of the Securities Act of 1933. The shares were issued to 6,766,900 holders of Envy Development PB, LLC and 233,100 holders of The Myelin Group, LLC. The Series D Preferred Stock carries a stated value of $3.00 per share and is convertible at any time at the holder’s option into one share of Common Stock.

The Company filed a Certificate of Designation with the Nevada Secretary of State to establish the terms of the Series D Preferred Stock. The preferred stock ranks senior to the Common Stock and Series B Preferred Stock, and on a parity with Series A Preferred Stock, as to liquidation. It ranks junior to Series A Preferred Stock regarding dividends. The Series D Preferred Stock does not carry a fixed or cumulative dividend but participates on an as-converted basis in any dividend paid on the Common Stock.

Additionally, the Company delivered an unsecured promissory note dated November 10, 2026, in the principal amount of $1,364,000 to the Sellers. This note, referred to as the Late Payment Note, satisfies late-payment damages and a late charge. It bears interest at 12% per annum and is payable in five equal monthly installments of $272,800, beginning December 5, 2026, with the remaining balance due on April 5, 2027.

The Series D Preferred Stock may be redeemed by the Company at its stated value only at its election, with approval from a majority of independent directors. Holders have no right to require redemption. If any shares remain outstanding on or after April 5, 2027, holders may request a review of their liquidity by the independent directors, though this is a procedural right only. The shares may only be transferred to affiliates of the holder and will not be listed on any exchange.